This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Cadila Pharmaceuticals Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations by Ashish Premkumar Gogia
Introduction
Ashish Premkumar Gogia is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of two patents to his name, Gogia is recognized for his work in enhancing the bioavailability and stability of pharmaceutical compositions.
Latest Patents
Gogia's latest patents include a formulation for stable liquid pharmaceutical compositions of curcumin. This invention focuses on achieving higher curcumin concentration and improved bioavailability without the use of buffers or molecular aggregation inhibitors. The curcumin is presented in a solubilized form, resulting in a stable liquid pharmaceutical composition. His other patent involves a stable oral pharmaceutical composition of taxoids, which enhances solubility and bioavailability. This composition comprises a taxoid, a solubilizer, a stabilizing agent, surfactants, solvents, and oil, with taxoid concentrations ranging from 0.1 to 10%.
Career Highlights
Gogia is currently associated with Cadila Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at Cadila Pharmaceuticals has allowed him to focus on developing innovative solutions that address critical health challenges.
Collaborations
Some of Gogia's coworkers include Bakulesh Mafatlal Khamar and Ritu Nitin Laddha. Their collaboration contributes to the dynamic environment at Cadila Pharmaceuticals, fostering innovation and research.
Conclusion
Ashish Premkumar Gogia's contributions to pharmaceutical innovations highlight his commitment to improving healthcare solutions. His patents reflect a deep understanding of the complexities involved in drug formulation and bioavailability.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
